Prescription for change: Improving competition to lower drug prices

WASHINGTON — In a new web video, Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott discusses the critical role and value of pharmacy benefit companies, the root cause of high prescription drug prices, and how solutions to boost competition, especially in the biosimilar marketplace, will be the most effective way to secure a more affordable future for patients.

Watch the full video here and below.

Learn more about public policy solutions that would promote competition in the prescription drug market and effectively lower prices for patients HERE.

Learn more about how pharmacy benefit companies secure savings, support better health outcomes, and provide choices to help expand access to quality prescription drug coverage for patients HERE.